Trial Parameters
Brief Summary
Primary Objective(s) To collect clinical data related to the treatment outcomes of Pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical intervention. Secondary Objective(s) To collect data on adverse events and complications related to IRE treatment. The AHPBA (Americas Hepato-Pancreato-Biliary Association) will be responsible for data collection and will periodically audit the data for quality assurance purposes. The AHPBA will review outcomes reported by each participating Research Institution and if outcomes are in the lower percentile, the investigators will be offered support to analyze the reasons for the suboptimal outcomes and may seek support to improve outcomes. The participating Research Institutions will receive a certificate annually that acknowledges their participation in the Research Project.
Eligibility Criteria
Inclusion Criteria: 1. more than 18 years of age 2. Diagnosed with pancreatic cancer and has consented to undergo the NanoKnife procedure per the treating physician 3. Willing and able to comply with the protocol requirements 4. Able to comprehend and sign the Informed Consent Form in English or Spanish Exclusion Criteria: * Patients who meet any of the following criteria will be excluded from the study: 1. Do not meet the Study Inclusion Criteria laid out above